S&P 500   4,263.75 (+0.81%)
DOW   33,129.55 (+0.39%)
QQQ   359.75 (+1.36%)
AAPL   173.66 (+0.73%)
MSFT   318.95 (+1.77%)
META   305.58 (+1.54%)
GOOGL   135.24 (+2.12%)
AMZN   127.00 (+1.83%)
TSLA   261.16 (+5.93%)
NVDA   440.41 (+1.20%)
NIO   8.83 (+2.56%)
BABA   84.08 (-0.54%)
AMD   104.07 (+3.99%)
T   14.65 (-0.88%)
F   11.99 (-0.66%)
MU   68.11 (+0.41%)
CGC   0.75 (+10.19%)
GE   108.85 (+1.01%)
DIS   79.32 (-0.28%)
AMC   8.34 (+6.24%)
PFE   33.31 (-1.74%)
PYPL   58.57 (+2.22%)
NFLX   376.90 (+0.04%)
S&P 500   4,263.75 (+0.81%)
DOW   33,129.55 (+0.39%)
QQQ   359.75 (+1.36%)
AAPL   173.66 (+0.73%)
MSFT   318.95 (+1.77%)
META   305.58 (+1.54%)
GOOGL   135.24 (+2.12%)
AMZN   127.00 (+1.83%)
TSLA   261.16 (+5.93%)
NVDA   440.41 (+1.20%)
NIO   8.83 (+2.56%)
BABA   84.08 (-0.54%)
AMD   104.07 (+3.99%)
T   14.65 (-0.88%)
F   11.99 (-0.66%)
MU   68.11 (+0.41%)
CGC   0.75 (+10.19%)
GE   108.85 (+1.01%)
DIS   79.32 (-0.28%)
AMC   8.34 (+6.24%)
PFE   33.31 (-1.74%)
PYPL   58.57 (+2.22%)
NFLX   376.90 (+0.04%)
S&P 500   4,263.75 (+0.81%)
DOW   33,129.55 (+0.39%)
QQQ   359.75 (+1.36%)
AAPL   173.66 (+0.73%)
MSFT   318.95 (+1.77%)
META   305.58 (+1.54%)
GOOGL   135.24 (+2.12%)
AMZN   127.00 (+1.83%)
TSLA   261.16 (+5.93%)
NVDA   440.41 (+1.20%)
NIO   8.83 (+2.56%)
BABA   84.08 (-0.54%)
AMD   104.07 (+3.99%)
T   14.65 (-0.88%)
F   11.99 (-0.66%)
MU   68.11 (+0.41%)
CGC   0.75 (+10.19%)
GE   108.85 (+1.01%)
DIS   79.32 (-0.28%)
AMC   8.34 (+6.24%)
PFE   33.31 (-1.74%)
PYPL   58.57 (+2.22%)
NFLX   376.90 (+0.04%)
S&P 500   4,263.75 (+0.81%)
DOW   33,129.55 (+0.39%)
QQQ   359.75 (+1.36%)
AAPL   173.66 (+0.73%)
MSFT   318.95 (+1.77%)
META   305.58 (+1.54%)
GOOGL   135.24 (+2.12%)
AMZN   127.00 (+1.83%)
TSLA   261.16 (+5.93%)
NVDA   440.41 (+1.20%)
NIO   8.83 (+2.56%)
BABA   84.08 (-0.54%)
AMD   104.07 (+3.99%)
T   14.65 (-0.88%)
F   11.99 (-0.66%)
MU   68.11 (+0.41%)
CGC   0.75 (+10.19%)
GE   108.85 (+1.01%)
DIS   79.32 (-0.28%)
AMC   8.34 (+6.24%)
PFE   33.31 (-1.74%)
PYPL   58.57 (+2.22%)
NFLX   376.90 (+0.04%)
NASDAQ:NERV

Minerva Neurosciences (NERV) Earnings Date, Estimates & Call Transcripts

$6.41
-0.29 (-4.33%)
(As of 04:00 PM ET)
Compare
Today's Range
$6.08
▼
$6.71
50-Day Range
$6.69
▼
$10.52
52-Week Range
$1.26
▼
$14.70
Volume
12,548 shs
Average Volume
397,882 shs
Market Capitalization
$44.81 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$11.00
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability

Earnings Summary

Upcoming
Earnings Date
Nov. 8Estimated
Actual EPS
(Aug. 1)
-$1.12 Missed By -$0.68
Consensus EPS
(Aug. 1)
-$0.44
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

NERV Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

NERV Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Minerva Neurosciences Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20232($1.63)($1.23)($1.43)
Q2 20232($1.22)($0.44)($0.83)
Q3 20232($1.19)($0.77)($0.98)
Q4 20232($1.18)($0.88)($1.03)
FY 20238($5.22)($3.32)($4.27)
Q1 20241($1.00)($1.00)($1.00)
Q2 20241($0.76)($0.76)($0.76)
Q3 20241($0.81)($0.81)($0.81)
Q4 20241($0.90)($0.90)($0.90)
FY 20244($3.47)($3.47)($3.47)

NERV Earnings Date and Information

Minerva Neurosciences last announced its earnings data on August 1st, 2023. The biopharmaceutical company reported ($1.12) earnings per share for the quarter, missing analysts' consensus estimates of ($0.44) by $0.68. Minerva Neurosciences has generated ($4.98) earnings per share over the last year (($4.98) diluted earnings per share). Earnings for Minerva Neurosciences are expected to grow in the coming year, from ($3.94) to ($3.44) per share. Minerva Neurosciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 8th, 2023 based off prior year's report dates.

Minerva Neurosciences Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
11/8/2023
Estimated)		------- 
8/1/2023Q2 2023($0.44)($1.12)($0.68)($1.12)--
5/15/2023Q1 2023($1.63)($1.31)+$0.32($1.31)--
3/8/2023Q4 2022($1.35)($1.26)+$0.09($1.26)--
11/9/2022Q3 2022($1.46)($1.29)+$0.17($1.29)--
8/9/2022Q2 2022($1.84)($1.63)+$0.21($1.63)--
5/4/2022Q1 2022($1.60)($1.84)($0.24)($0.23)--    
3/1/2022Q4 2021($1.60)($0.96)+$0.64$0.26--
11/8/2021Q3 2021($1.76)($1.76)-($0.22)--    
8/2/2021Q2 2021($1.36)($2.00)($0.64)($0.25)--    
5/12/2021Q1$1.60($1.68)($3.28)($0.21)--  
3/7/2021Q4 2020($1.52)($1.44)+$0.08($0.17)--  
11/2/2020Q3 2020($1.76)($1.52)+$0.24($0.19)--  












Minerva Neurosciences Earnings - Frequently Asked Questions

When is Minerva Neurosciences's earnings date?

Minerva Neurosciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 8th, 2023 based off last year's report dates. Learn more on NERV's earnings history.

Did Minerva Neurosciences beat their earnings estimates last quarter?

In the previous quarter, Minerva Neurosciences (NASDAQ:NERV) missed the analysts' consensus estimate of ($0.44) by $0.68 with a reported earnings per share (EPS) of ($1.12). Learn more on analysts' earnings estimate vs. NERV's actual earnings.

How much revenue does Minerva Neurosciences generate each year?

Minerva Neurosciences (NASDAQ:NERV) has a recorded annual revenue of $41.18 million.

How much profit does Minerva Neurosciences generate each year?

Minerva Neurosciences (NASDAQ:NERV) has a recorded net income of -$32.11 million. NERV has generated -$4.98 earnings per share over the last four quarters.

What is Minerva Neurosciences's EPS forecast for next year?

Minerva Neurosciences's earnings are expected to grow from ($3.94) per share to ($3.44) per share in the next year.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:NERV) was last updated on 10/4/2023 by MarketBeat.com Staff

My Account -